Skip to main content
Funded Studies

Johannes Levin, MD

Chief Medical Officer, MODAG at LMU Klinikum, Department of Neurology

Professor for Clinical Neurodegeneration

Location: Munich Germany

Dr. Johannes Levin is chief medical officer of MODAG, professor for clinical neurodegeneration and head of the Outpatient Clinic for Neurodegenerative Diseases at the department of neurology at the Ludwig-Maximilian-University (LMU) in Munich, Germany and deputy head of clinical research at the German Center for Neurodegenerative Diseases in Munich. Prof. Levin studied medicine at LMU Munich, Universidad de Granada (Spain) and Harvard Medical School (USA). He holds a Doctor of Medicine from the LMU and is a board-certified neurologist at the Bavarian Chamber of Physicians. He has published more than 200 scientific papers and his work has contributed to defining the natural history and treatment of neurodegenerative diseases. Professor Levin served as Principal Investigator to many clinical studies including the largest interventional Multiple System Atrophy (MSA) trial in Germany and international cohort studies such as the Dominantly Inherited Alzheimer’s Network (DIAN).


Associated Grants

  • Pet Imaging to Determine Regional and Temporal Trajectories of Reactive Astrocytosis in Parkinson’s Disease

    2022


  • Pharmacokinetics, Food Effects, Safety and Tolerability of Aggregation Inhibitor Anle138b in Parkinson´s Disease

    2022


  • Anle138b Clinical Phase 1 Studies: Food Effect, Safety and Tolerability as well as Pharmacokinetics in Parkinson´s Disease Patients

    2020


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.